Vaginal misoprostol enhances intrauterine insemination

Human Reproduction

Volumn 16, Issue 1, 2001, Pages 96-101

  Brown, Samuel E ^a,d   Toner, James P ^a,e   Schnorr, John A ^a   Williams, Shaun C ^a   Gibbons, William E ^a   De Ziegler, Dominique ^b,c   Oehninger, Sergio ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Groupement Hospitalier de l'Ouest Lemanique   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d Florida Institute for Reproductive Medicine   (United States)

^e Atlanta Ctr for Repro Medicine   (United States)

Author keywords

Intrauterine insemination; Misoprostol; Pregnancy; Prostaglandin; Vaginal

Indexed keywords

CLOMIFENE; FOLLITROPIN; MISOPROSTOL; PROSTAGLANDIN E1 DERIVATIVE; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CANNULA; CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HUMAN; INFERTILITY; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; OVARY CYCLE; OVULATION INDUCTION; PAIN ASSESSMENT; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 0035176514     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.1.96     Document Type: Article

References (35)

1. Analysis of the direct effects of prostaglandins on human sperm function
2. Cox's regression model for counting processes: A large sample study
3. A quantitative determination of the content of contractive substances in human sperm and their significance for the motility and vitality of the spermatozoa
4. The natural variations in prostaglandin concentration in human seminal fluid and its relation to sperm quality
5. Absence of prostaglandins in semen of men with cystic fibrosis is an indication of the contribution of the seminal vesicles
6. The relation between fertility and prostaglandin content of seminal fluid in man
7. Chemistry and synthetic development of misoprostol
8. The contractile response of the human uterus, fallopian tubes, and ovary to prostaglandins in vivo
9. Methotrexate and misoprostol for early abortion
10. Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview
11. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women
12. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia
13. In vitro responses of the spermatozoa-cervical mucus system treated with prostaglandin (F2a)
14. The fertility potential of male cystic fibrosis patients
15. The uterine effects of vaginally administered prostaglandin E2
16. Therapeutic intrauterine insemination improves with gonadotropin ovarian stimulation
17. The influence of seminal fluid on the motility of the nonpregnant human uterus
18. Pain intensity and pain relief after surgery. A comparison between patients' reported assessments and nurses' and physicians' observations
19. The effect of prostaglandin E on rabbit sperm transport
20. Biochemistry of seminal plasma and male accessory fluid
21. Intracytoplasmic sperm injection: Results from Norfolk, USA
22. Approaching the next millennium: How should we manage andrology diagnosis in the intracytoplasmic sperm injection era?
23. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol
24. Effect of intravenous administration of prostaglandin E1, and F2 on the contractility of the non-pregnant human uterus in vivo
25. Introducing epidural fentanyl for on-ward pain relief after major surgery
26. Misoprostol for cervical ripening and labor induction: A meta-analysis
27. Relative immunosuppressive activity of human seminal prostaglandins
28. Prostaglandin concentrations in the semen of fertile men
29. Intrauterine infusion of prostaglandin E2 and subsequent luteal function in cattle